MolBiC: the cell-based landscape illustrating molecular bioactivities
Open Access
- 7 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D1683-D1691
Abstract
The measurement of cell-based molecular bioactivity (CMB) is critical for almost every step of drug development. With the booming application of AI in biomedicine, it is essential to have the CMB data to promote the learning of cell-based patterns for guiding modern drug discovery, but no database providing such information has been constructed yet. In this study, we introduce MolBiC, a knowledge base designed to describe valuable data on molecular bioactivity measured within a cellular context. MolBiC features 550 093 experimentally validated CMBs, encompassing 321 086 molecules and 2666 targets across 988 cell lines. Our MolBiC database is unique in describing the valuable data of CMB, which meets the critical demands for CMB-based big data promoting the learning of cell-based molecular/pharmaceutical pattern in drug discovery and development. MolBiC is now freely accessible without any login requirement at: https://idrblab.org/MolBiC/.Keywords
Funding Information
- National Natural Science Foundations of China (82373790, 22220102001, 81872798, U1909208)
- Natural Science Foundation of Zhejiang Province (LR21H300001)
- Fundamental Research Funds for Central Universities (2018QNA7023)
- National Key R&D Program of China (2022YFC3400501)
- Double Top-Class University (181201*194232101)
- Key R&D Program of Zhejiang (2020C03010)
- Westlake Laboratory
- Leading Talent of the ‘Ten Thousand Plan’ National High-Level Talents Special Support Plan of China
- Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare
- Alibaba Cloud
- The Information Technology Center of Zhejiang University
This publication has 91 references indexed in Scilit:
- Bioorthogonally activated reactive species for target identificationChem, 2024
- ANPELA: Significantly Enhanced Quantification Tool for Cytometry‐Based Single‐Cell ProteomicsAdvanced Science, 2023
- Drug discovery for enzymesDrug Discovery Today, 2021
- High-Throughput Screening: today’s biochemical and cell-based approachesDrug Discovery Today, 2020
- Complex Formation between VEGFR2 and the β2-AdrenoceptorCell Chemical Biology, 2019
- Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approachEuropean Journal of Medicinal Chemistry, 2019
- Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2018
- Roles of Caspases in Necrotic Cell DeathCell, 2016
- Dual-acting histone deacetylase-topoisomerase I inhibitorsBioorganic & Medicinal Chemistry Letters, 2013
- Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activityBioorganic & Medicinal Chemistry Letters, 2010